Evidence Hub

Microplastics and nano-plastics as emerging gut-brain axis disruptors: mechanistic insights, health implications, and future direction

Patra SS, Panda S, Turuk J, Pati S

Frontiers in public health, 2026

Abstract

Plastics are synthetic polymers widely used for their versatility, longer shelf life, and low cost. However, the non-biodegradable nature of conventional plastics has led to accumulation of microplastics (MPs; Faecalibacterium, Roseburia, and Bifidobacterium, while stimulating the growth of opportunistic pathogens such as Desulfovibrio spp. Subsequent reductions in short-chain fatty acid generation induce lipopolysaccharide release and downregulation of tight junction proteins that compromise intestinal barrier integrity and expedite the translocation of MNPs, microbial products, and pro-inflammatory determinants into systemic circulation. MNPs then cross the blood-brain barrier by receptor-mediated routes, paracellular diffusion, or transcytosis, which is exacerbated by inflammation and oxidative stress. Excessive ROS further cause mitochondrial dysfunction, neuroinflammation, microglial activation, neurotransmitter imbalance, and pathological protein aggregation. This is a narrative review, focusing on integrating current evidence on the role of MNPs in disturbing the gut-brain axis through gut dysbiosis, intestinal barrier dysfunction, increased oxidative stress, inflammation, and altered neurochemical signaling. It further highlights the consequences of these changes in systemic health, identifies key knowledge gaps, and outlines future research priorities to better understand and mitigate the health risks.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free